Cargando…

Identification of adriamycin resistance genes in breast cancer based on microarray data analysis

BACKGROUND: Breast cancer is a common malignant tumor with increasing incidence worldwide. This study aimed to investigate the molecular mechanisms of the adriamycin (ADR) resistance in breast cancer. METHODS: The GSE76540 dataset downloaded from the National Center for Biotechnology Information (NC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yan, Lin, Yingfeng, Cui, Zhaolei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797850/ https://www.ncbi.nlm.nih.gov/pubmed/35117349 http://dx.doi.org/10.21037/tcr-19-2145

Ejemplares similares

Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis
por: Wang, Zhipeng, et al.
Publicado: (2015)

Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells
por: Cao, Bei, et al.
Publicado: (2013)

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin
por: He, Ye, et al.
Publicado: (2015)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
por: Qi, Min, et al.
Publicado: (2021)

Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer
por: Hong, Woo Sung, et al.
Publicado: (2013)

Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line.
por: Citro, G., et al.
Publicado: (1991)

PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer
por: Chen, Yongxia, et al.
Publicado: (2021)

YB-1 Expression Is Associated with Lymph Node Metastasis and Drug Resistance to Adriamycin in Breast Cancer
por: Dong, Hanzhi, et al.
Publicado: (2023)

Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells
por: XIE, XIAO-HONG, et al.
Publicado: (2014)

NBDHEX re‐sensitizes adriamycin‐resistant breast cancer by inhibiting glutathione S‐transferase pi
por: Sha, Huanhuan, et al.
Publicado: (2022)

Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells
por: Chen, Wei-xian, et al.
Publicado: (2018)

Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line
por: Manh Hung, Le Van, et al.
Publicado: (2018)

Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells
por: Sun, Wenxia, et al.
Publicado: (2013)

Metastatic Metaplastic Breast Cancer Successfully Treated with Adriamycin and Cisplatin
por: Hayashino, Kenta, et al.
Publicado: (2022)

Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data
por: Wang, Ya-Wen, et al.
Publicado: (2018)

Identification of key genes associated with gastric cancer based on DNA microarray data
por: SUN, HUI
Publicado: (2016)

Downregulation of hypermethylated in cancer-1 by miR-4532 promotes adriamycin resistance in breast cancer cells
por: Feng, Fan, et al.
Publicado: (2018)

Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line
por: Li, Jie, et al.
Publicado: (2001)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Identification of key genes associated with cervical cancer by comprehensive analysis of transcriptome microarray and methylation microarray
por: LIU, MING-YAN, et al.
Publicado: (2016)

Identification and Analysis of Genes Underlying Bone Mineral Density by Integrating Microarray Data of Osteoporosis
por: Zhang, Haihong, et al.
Publicado: (2020)

USP37 downregulation elevates the Chemical Sensitivity of Human Breast Cancer Cells to Adriamycin
por: Qin, Tao, et al.
Publicado: (2021)

Cancer-testis antigen lactate dehydrogenase C4 in hepatocellular carcinoma: a promising biomarker for early diagnosis, efficacy evaluation and prognosis prediction
por: Cui, Zhaolei, et al.
Publicado: (2020)

Mechanism of the enhancing effects of miR-93 on resistance of breast cancer MCF-7 cells to adriamycin
por: Wang, Qian, et al.
Publicado: (2018)

Small extracellular vesicles deliver TGF‐β1 and promote adriamycin resistance in breast cancer cells
por: Tan, Chunli, et al.
Publicado: (2021)

LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer
por: Ma, Siping, et al.
Publicado: (2018)

Dynamic Metabolic Response to Adriamycin-Induced Senescence in Breast Cancer Cells
por: You, Rong, et al.
Publicado: (2018)

Identification and analysis of key genes associated with ulcerative colitis based on DNA microarray data
por: Song, Ruifeng, et al.
Publicado: (2018)

Model-based cluster analysis of microarray gene-expression data
por: Pan, Wei, et al.
Publicado: (2002)

Acute Induction of Adriamycin‐resistance in Human Colon Carcinoma HT‐29 Cells Exposed to a Sublethal Dose of Adriamycin
por: Tomida, Akihiro, et al.
Publicado: (1995)

Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Stability of gene contributions and identification of outliers in multivariate analysis of microarray data
por: Baty, Florent, et al.
Publicado: (2008)

Identification of significant periodic genes in microarray gene expression data
por: Chen, Jie
Publicado: (2005)

Microarray Data Analysis of Gene Expression Evolution
por: Lin, Honghuang
Publicado: (2009)

Identification of core genes and clinical roles in pregnancy-associated breast cancer based on integrated analysis of different microarray profile datasets
por: Zhang, Jiao, et al.
Publicado: (2019)

A Marine Anthraquinone SZ-685C Overrides Adriamycin-Resistance in Breast Cancer Cells through Suppressing Akt Signaling
por: Zhu, Xun, et al.
Publicado: (2012)

Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.
por: Nishio, K., et al.
Publicado: (1990)

Gene expression profile analysis of pancreatic cancer based on microarray data
por: LONG, JIN, et al.
Publicado: (2016)

Analysis of Cardiac Adverse Reactions Caused by Different Doses of Adriamycin Chemotherapy in Patients with Breast Cancer
por: Hu, Guangwen, et al.
Publicado: (2022)

RBM38 is negatively regulated by miR-320b and enhances Adriamycin resistance in breast cancer cells
por: Ke, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m2778r8ma0ejdihghkr3t5srl3